Beneficial action of new angiotensin-converting enzyme inhibitor (SQ 14,225) in hemorrhagic shock in cats.
D000804:Angiotensin II / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D002403:Cathepsins / Q000097:blood; D002415:Cats; D004353:Drug Evaluation, Preclinical; D005966:Glucuronidase / Q000097:blood; D008297:Male; D009201:Myocardial Depressant Factor / Q000096:biosynthesis; D011392:Proline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012771:Shock, Hemorrhagic / Q000188:drug therapy* / Q000201:enzymology
D000806:Angiotensin-Converting Enzyme Inhibitors; D009201:Myocardial Depressant Factor; D000804:Angiotensin II; D011392:Proline; D005966:Glucuronidase; D002403:Cathepsins